Publicaciones en las que colabora con Sonia Molina Pinelo (29)

2023

  1. Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer

    Cancers, Vol. 15, Núm. 5

  2. Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2021

  1. Identification of predictive biomarkers of response to hsp90 inhibitors in lung adenocarcinoma

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-18

2018

  1. Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer

    Oncotarget, Vol. 9, Núm. 28, pp. 19945-19960

  2. Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer

    Oncotarget, Vol. 9, Núm. 4, pp. 4395-4410

  3. MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma

    Journal of Experimental and Clinical Cancer Research, Vol. 37, Núm. 1

  4. The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer

    Oncotarget, Vol. 8, Núm. 62, pp. 105196-105210

  2. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement

    Clinical Lung Cancer, Vol. 18, Núm. 6, pp. 667-674.e1

2016

  1. 19P Comparative effectiveness analysis of HSP90 inhibitors in non-small cell lung cancer

    Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S63-S64

  2. 20P Context-dependent role of FGFR4 in lung tumorogenesis

    Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S64

  3. Analysis of the immune microenvironment in resected non-small cell lung cancer: The prognostic value of different T lymphocyte markers

    Oncotarget, Vol. 7, Núm. 33, pp. 52849-52861

  4. Current Challenges in Cancer Treatment

    Clinical Therapeutics, Vol. 38, Núm. 7, pp. 1551-1566

  5. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF)

    Journal of Thoracic Oncology, Vol. 11, Núm. 12, pp. 2183-2192

  6. Proteomic-based approaches for the study of cytokines in lung cancer

    Disease Markers, Vol. 2016

  7. Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications

    Disease Markers, Vol. 2016

2015

  1. Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer

    Oncotarget, Vol. 6, Núm. 8, pp. 6151-6159

2014

  1. MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

    BMC Cancer, Vol. 14, Núm. 1

  2. MicroRNA clusters: Dysregulation in lung adenocarcinoma and COPD

    European Respiratory Journal, Vol. 43, Núm. 6, pp. 1740-1749

  3. MicroRNA-dependent regulation of transcription in non-small cell lung cancer

    PLoS ONE, Vol. 9, Núm. 3